Case number 1:22-cv-00017
Ferring Pharmaceuticals Inc. et al v. Eugia Pharma Specialties Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 26, 2023 | 117 | SO ORDERED re 115 Joint STIPULATION TO EXTEND TIME for Opening expert report, rebuttal expert report, reply expert report to June 23, 2023, July 25, 2023, August 15, 2023, respectively (Set/Reset Scheduling Order Deadlines - Opening Expert Reports due by 6/23/2023. Rebuttal Expert Reports due by 7/25/2023. Reply Expert Reports due by 8/15/2023). ORDERED by Judge Maryellen Noreika on 6/26/2023. (dlw) (Entered: 06/26/2023) (3) |
| Jun 23, 2023 | 115 | Joint STIPULATION TO EXTEND TIME Opening expert report, rebuttal expert report, reply expert report to June 23, 2023, July 25, 2023, August 15, 2023, respectively - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 06/23/2023) (3) |
| Jun 23, 2023 | 116 | NOTICE OF SERVICE of Opening Expert Report of Philip E. Dawson, Ph.D. filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) (Entered: 06/23/2023) (2) |
| Jun 20, 2023 | 113 | REDACTED VERSION of 109 Letter by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd. (Neff, Carl) Modified on 6/20/2023 (dlw). (Entered: 06/20/2023) (17) |
| Jun 20, 2023 | 114 | REDACTED VERSION of 110 Letter by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd. (Neff, Carl) Modified on 6/20/2023 (dlw). (Entered: 06/20/2023) (11) |
| Jun 15, 2023 | 112 | STIPULATION TO EXTEND TIME for Parties to file redacted versions of the Plaintiffs June 8, 2023 Discovery Dispute Letter filed under seal (D.I. 109) and Defendants June 9, 2023 Discovery Dispute Letter (D.I. 110) to June 19, 2023 - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) (Entered: 06/15/2023) (2) |
| Jun 12, 2023 | 111 | ORAL ORDER Setting Hearing 109 Letter; 110 Letter - Having reviewed the parties' discovery dispute letters, IT IS HEREBY ORDERED that an IN-PERSON hearing is set for 6/21/2023 at 03:00 PM in Courtroom 4A before Judge Maryellen Noreika. ORDERED by Judge Maryellen Noreika on 6/12/2023. (dlw) (Entered: 06/12/2023) (0) |
| Jun 9, 2023 | 110 | [SEALED] Letter to The Honorable Maryellen Noreika from Carl D. Neff regarding discovery dispute. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Neff, Carl) (Entered: 06/09/2023) (0) |
| Jun 8, 2023 | 109 | [SEALED] Letter to The Honorable Maryellen Noreika from Dana K. Severance regarding discovery dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Certificate of Service)(Severance, Dana) (Entered: 06/08/2023) (0) |
| Jun 7, 2023 | 108 | STIPULATION TO EXTEND TIME for all expert discovery deadlines to see Stipulation - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 06/07/2023) (3) |
| Jun 6, 2023 | 107 | ORAL ORDER - Consistent with the Scheduling Order, the parties contacted chambers to request a teleconference date for Plaintiffs' anticipated motion to strike certain portions of Defendants' Final Noninfringement Contentions, or in the alternative, for fact discovery to be reopened. IT IS HEREBY ORDERED that Plaintiffs' opening letter (not to exceed three (3) pages) shall be submitted on or before 6/8/2023 and Defendants' answering letter (not to exceed three (3) pages) shall be submitted on or before 6/9/2023. Once the Court reviews the letters it will determine the next step (e.g. rule on the papers, set a teleconference, request further submissions). ORDERED by Judge Maryellen Noreika on 6/6/2023. (dlw) (Entered: 06/06/2023) (0) |
| May 26, 2023 | 106 | NOTICE OF SERVICE of Defendants Final Noninfringement Contentions for U.S. Patent No. 8,828,938 filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 05/26/2023) (2) |
| May 19, 2023 | 105 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions for U.S. Patent No. 8,828,938 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) (Entered: 05/19/2023) (2) |
| May 3, 2023 | 104 | STIPULATION TO EXTEND TIME to serve final infringement and non-infringement contentions to May 19, 2023 and May 26, 2023 - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Severance, Dana) (Entered: 05/03/2023) (2) |
| Apr 17, 2023 | 102 | REDACTED VERSION of 98 Letter, by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Severance, Dana) (Entered: 04/17/2023) (7) |
| Apr 17, 2023 | 103 | REDACTED VERSION of 100 Letter by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) (Entered: 04/17/2023) (4) |
| Apr 13, 2023 | 101 | ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the April 13, 2023 discovery dispute teleconference shall serve as the Order of the Court. Ordered by Judge Jennifer L. Hall on 4/13/2023. (ceg) (Entered: 04/13/2023) (0) |
| Apr 12, 2023 | 99 | REDACTED VERSION of 95 MOTION Teleconference to Resolve Discovery Dispute by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Severance, Dana) Modified on 4/12/2023 (ceg). (Entered: 04/12/2023) (4) |
| Apr 12, 2023 | 100 | [SEALED] Letter to The Honorable Jennifer L. Hall from Carl D. Neff regarding discovery dispute - re 97 Order Setting Teleconference,,,,. (Attachments: # 1 Certificate of Service)(Neff, Carl) (Entered: 04/12/2023) (0) |
| Apr 10, 2023 | 98 | [SEALED] Letter to The Honorable Jennifer L. Hall from Dana K. Severance regarding discovery dispute - re 97 Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Certificate of Service)(Severance, Dana) (Entered: 04/10/2023) (0) |
| Apr 5, 2023 | 95 | [SEALED] MOTION for Teleconference to Resolve Discovery Dispute - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Attachments: # 1 Certificate of Service) (Bourke, Mary) Modified on 4/5/2023 (ceg). (Entered: 04/05/2023) (0) |
| Apr 5, 2023 | 96 | SO ORDERED re 91 STIPULATION TO EXTEND TIME for multiple Scheduling Order deadlines (Set/Reset Scheduling Order Deadlines - Fact Discovery completed by 4/28/2023. Opening Expert Reports due by 6/9/2023. Rebuttal Expert Reports due by 7/14/2023. Reply Expert Reports due by 8/11/2023. Expert Discovery due by 8/25/2023). Signed by Judge Maryellen Noreika on 4/5/2023. (dlw) (Entered: 04/05/2023) (4) |
| Apr 5, 2023 | 97 | ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Disputes (D.I. 95 ). A discovery dispute teleconference is scheduled for April 13, 2023 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than April 10, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than April 12, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 4/5/2023. (ceg) (Entered: 04/05/2023) (0) |
| Mar 31, 2023 | 93 | ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for a discovery dispute regarding 30(b)(6) deposition testimony, IT IS HEREBY ORDERED that this discovery dispute is referred to Magistrate Judge Hall. The parties are directed to file Magistrate Judge Hall's "Motion for Teleconference to Resolve Discovery/Protective Order Disputes" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-jennifer-l-hall, forms. ORDERED by Judge Maryellen Noreika on 3/31/2023. (dlw) (Entered: 03/31/2023) (0) |
| Mar 31, 2023 | 94 | REDACTED VERSION of 85 Stipulation by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Severance, Dana) (Entered: 03/31/2023) (4) |
| Mar 30, 2023 | 90 | ORAL ORDER re 88 STIPULATION TO EXTEND TIME for multiple Scheduling Order deadlines - IT IS HEREBY ORDERED that the stipulation is DENIED for failure to follow Rule 16.4 of the Local Rules of Civil Practice and Procedure of the United States District Court for the District of Delaware. ORDERED by Judge Maryellen Noreika on 3/30/2023. (dlw) (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 91 | STIPULATION TO EXTEND TIME for multiple Scheduling Order deadlines to see Stipulation - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Severance, Dana) (Main Document 91 replaced on 4/5/2023) (dlw). (Entered: 03/30/2023) (4) |
| Mar 30, 2023 | 92 | STIPULATION TO EXTEND TIME for Parties to file a redacted version of the March 23, 2023 Stipulation filed under seal (D.I. 85) to March 31, 2023 - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) (Entered: 03/30/2023) (2) |
| Mar 29, 2023 | 88 | STIPULATION TO EXTEND TIME for multiple Scheduling Order deadlines to see Stipulation - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Main Document 88 replaced on 3/29/2023) (dlw). (Entered: 03/29/2023) (3) |
| Mar 29, 2023 | 89 | NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs First Set of Requests for Admission (Nos. 1-23) and Reponses and Objections to Plaintiffs Second Set of Interrogatories (Nos. 15-19) filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 03/29/2023) (2) |
| Mar 28, 2023 | 87 | ORAL ORDER re 84 Letter: Defendants' request for a one-day extension to file the parties' proposed stipulation is granted. Ordered by Judge Jennifer L. Hall on 3/28/2023. (ceg) (Entered: 03/28/2023) (0) |
| Mar 27, 2023 | 86 | NOTICE to Take Deposition of Sivaram SDVN filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) (Entered: 03/27/2023) (2) |
| Mar 23, 2023 | 85 | [SEALED] STIPULATION by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Attachments: # 1 Certificate of Service)(Bourke, Mary) (Entered: 03/23/2023) (0) |
| Mar 22, 2023 | 83 | NOTICE to Take Deposition of Muralidharan Chandrakesan filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) (Entered: 03/22/2023) (2) |
| Mar 22, 2023 | 84 | Letter to Magistrate Judge Jennifer L. Hall from Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and Auromedics Pharma LLC regarding requesting a one-day extension to file a stipulation in this action narrowing the issues in this case. (Attachments: # 1 Text of Proposed Order)(Neff, Carl) (Entered: 03/22/2023) (Main Document) (1) |
| Mar 22, 2023 | 84 | Letter to Magistrate Judge Jennifer L. Hall from Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and Auromedics Pharma LLC regarding requesting a one-day extension to file a stipulation in this action narrowing the issues in this case. (Attachments: # 1 Text of Proposed Order)(Neff, Carl) (Entered: 03/22/2023) (Text of Proposed Order) (1) |
| Mar 16, 2023 | 82 | ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the March 16, 2023 discovery dispute teleconference shall serve as the Order of the Court. Ordered by Judge Jennifer L. Hall on 3/16/2023. (ceg) (Entered: 03/16/2023) (0) |
| Mar 14, 2023 | 81 | ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 80 ). A discovery dispute teleconference is scheduled for March 16, 2023 at 10:00 AM Eastern Time before Judge Jennifer L. Hall. No letters shall be filed. The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. Ordered by Judge Jennifer L. Hall on 3/14/2023. (ceg) (Entered: 03/14/2023) (0) |
| Mar 10, 2023 | 79 | NOTICE of Subpoena to A. Nagana Goud by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 03/10/2023) (Main Document) (1) |
| Mar 10, 2023 | 80 | MOTION for Discovery Teleconference to Resolve Discovery Dispute - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 03/10/2023) (5) |
| Mar 10, 2023 | 79 | NOTICE of Subpoena to A. Nagana Goud by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S (Attachments: # 1 Exhibit A)(Bourke, Mary) (Entered: 03/10/2023) (Exhibit A) (4) |
| Mar 8, 2023 | 78 | ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for a discovery dispute, IT IS HEREBY ORDERED that this discovery dispute is referred to Magistrate Judge Hall. The parties are directed to file Magistrate Judge Hall's "Motion for Teleconference to Resolve Discovery/Protective Order Disputes" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-jennifer-l-hall, forms. ORDERED by Judge Maryellen Noreika on 3/8/2023. (dlw) (Entered: 03/08/2023) (0) |
| Feb 27, 2023 | 77 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Admission (Nos. 1-23), (2) Plaintiffs' Second Set of Interrogatories (Nos. 15-19), and (3) Amended Notice of Deposition of Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and Auromedics Pharma LLC filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) (Entered: 02/27/2023) (2) |
| Feb 8, 2023 | 75 | SO ORDERED re 73 Stipulation and Order for Partial Stay - IT IS HEREBY ORDERED that: (1) This litigation is bifurcated. The October 23, 2023 trial is limited to validity and infringement of the '938 patent; (2) This litigation is stayed with respect to the infringement and validity of claims 3 and 13 of the '359 patent, claims 16 and 26 of the '739 patent, claims 3, 5, 8 and 14 of the '870 patent, claim 2 of the '085 patent, and claim 2 of the '398 patent; (3) The '081 and '999 patents are dismissed without prejudice; and (4) Plaintiffs' 28 Motion for Voluntary Dismissal of Claims Related to U.S. Patent Nos. 8,841,081 and 9,877,999 is DENIED AS MOOT. SEE STIPULATION FOR COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 2/8/2023. (dlw) (Entered: 02/08/2023) (6) |
| Feb 8, 2023 | 76 | SO ORDERED re 74 STIPULATION TO EXTEND TIME to extend fact discovery deadlines (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 3/31/2023. Final infringement and invalidity contentions served by 4/12/2023. Final validity and non-infringement contentions served by 4/26/223. Final supplementation of identification of all accused products and invalidity references served by 4/26/2023). Signed by Judge Maryellen Noreika on 2/8/2023. (dlw) (Entered: 02/08/2023) (3) |
| Feb 7, 2023 | 73 | STIPULATION and Proposed Order to Stay by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 02/07/2023) (6) |
| Feb 7, 2023 | 74 | STIPULATION TO EXTEND TIME to extend fact discovery deadlines to (see Stipulation) - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 02/07/2023) (3) |
| Jan 31, 2023 | 72 | SO ORDERED re 70 Stipulation and Order Regarding Claim Construction. Claim Construction Scheduling Order Deadlines TERMINATED. Signed by Judge Maryellen Noreika on 1/31/2023. (dlw) (Entered: 01/31/2023) (5) |
| Jan 30, 2023 | 71 | ORAL ORDER Setting Teleconference - IT IS HEREBY ORDERED that a Telephone Conference is set for 1/31/2023 at 10:00 AM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 1/30/2023. (dlw) (Entered: 01/30/2023) (0) |
| Jan 25, 2023 | 69 | Letter to The Honorable Maryellen Noreika from Mary W. Bourke regarding response to Court's Oral Order (D.I. 68) - re 68 Oral Order,,. (Attachments: # 1 Exhibit Stipulation and [Proposed] Order to Stay)(Bourke, Mary) (Attachment 1 replaced on 1/26/2023) (dlw). (Entered: 01/25/2023) (Main Document) (1) |
| Jan 25, 2023 | 70 | STIPULATION and Proposed Order Regarding Claim Construction by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Main Document 70 replaced on 1/26/2023) (dlw). (Entered: 01/25/2023) (5) |
| Jan 25, 2023 | 69 | Letter to The Honorable Maryellen Noreika from Mary W. Bourke regarding response to Court's Oral Order (D.I. 68) - re 68 Oral Order,,. (Attachments: # 1 Exhibit Stipulation and [Proposed] Order to Stay)(Bourke, Mary) (Attachment 1 replaced on 1/26/2023) (dlw). (Entered: 01/25/2023) (Exhibit Stipulation and [Proposed] Order to Stay) (6) |
| Jan 23, 2023 | 68 | ORAL ORDER - Having been advised by the parties of their inability to come to an agreement on a proposed form of stipulation for a partial stay of this action, IT IS HEREBY ORDERED that, on or before 1/25/2023, the parties shall submit the proposed Stipulation reflecting the parties' competing provisions under a generic, non-argumentative cover enclosure letter. In the meantime, this case has NOT been stayed and the parties should be proceeding accordingly. IT IS FURTHER ORDERED that the stipulations filed at D.I. 66 and 67 are TERMINATED. ORDERED by Judge Maryellen Noreika on 1/23/2023. (dlw) (Entered: 01/23/2023) (0) |
| Jan 20, 2023 | 67 | STIPULATION TO EXTEND TIME for parties to file the Stipulation and [Proposed] Order to Stay to January 23, 2023 - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) (Entered: 01/20/2023) (2) |
| Jan 13, 2023 | 66 | STIPULATION TO EXTEND TIME see Stipulation to - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 01/13/2023) (3) |
| Jan 5, 2023 | 64 | STIPULATION TO EXTEND TIME for multiple deadlines in the Scheduling Order to see Stipulation for further deadlines - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 01/05/2023) (3) |
| Jan 5, 2023 | 65 | SO ORDERED re 64 STIPULATION TO EXTEND TIME for multiple deadlines in the Scheduling Order to see Stipulation for further deadlines (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 2/7/2023). Signed by Judge Maryellen Noreika on 1/5/2023. (dlw) (Entered: 01/05/2023) (3) |
| Dec 30, 2022 | 63 | Letter to The Honorable Maryellen Noreika from Defendants regarding re. proposed stay. (Neff, Carl) (Entered: 12/30/2022) (1) |
| Dec 16, 2022 | 62 | Letter to The Honorable Maryellen Noreika from Defendants regarding Defendants' proposal to stay this litigation. (Neff, Carl) (Entered: 12/16/2022) (2) |
| Dec 6, 2022 | 61 | Joint Letter to The Honorable Maryellen Noreika from the parties regarding Defendants' proposal to stay this litigation. (Neff, Carl) (Entered: 12/06/2022) (3) |
| Nov 29, 2022 | 60 | ORAL ORDER - WHEREAS, consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for Defendants' anticipated motion to stay. THEREFORE, IT IS HEREBY ORDERED that, on or before 12/6/2022, the parties shall file a joint letter stating what the request for stay is based on, a brief statement of the opposition, and the proposal for letter briefing the issue. ORDERED by Judge Maryellen Noreika on 11/29/2022. (dlw) (Entered: 11/29/2022) (0) |
| Nov 21, 2022 | 58 | STIPULATION TO EXTEND TIME for multiple deadlines in the Scheduling Order to (see Stipulation) - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 11/21/2022) (3) |
| Nov 21, 2022 | 59 | SO ORDERED re 58 STIPULATION TO EXTEND TIME for multiple deadlines in the Scheduling Order (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 1/31/2023). SEE STIPULATION FOR FURTHER DEADLINES. Signed by Judge Maryellen Noreika on 11/21/2022. (dlw) (Entered: 11/21/2022) (3) |
| Nov 10, 2022 | 57 | STIPULATION TO EXTEND TIME for the parties to exchange a list of those claim term(s)/phrase(s) that they believe need construction and their proposed claim construction of those term(s)/phrase(s) to December 7, 2022 - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 11/10/2022) (2) |
| Nov 3, 2022 | 56 | NOTICE OF SERVICE of Defendants First Set of Interrogatories to Plaintiffs (Nos. 1-7) and Notice of Deposition of Plaintiffs Ferring Pharmaceuticals Inc., Ferring International Center S.A., Ferring B.V. and Polypeptide Laboratories A/S filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 11/03/2022) (2) |
| Oct 28, 2022 | 55 | NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 26 and 30(b)(6) filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 10/28/2022) (2) |
| Oct 5, 2022 | 54 | NOTICE OF SERVICE of Defendants Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-14) and Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-42 and 57-60) filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 10/05/2022) (2) |
| Sep 28, 2022 | 53 | NOTICE OF SERVICE of Notice of Deposition of Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and Auromedics Pharma LLC filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/28/2022) (2) |
| Sep 26, 2022 | 45 | NOTICE to Take Deposition of A. Nagana Goud on December 6, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 46 | NOTICE to Take Deposition of Adarsh Jain on December 1, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 47 | NOTICE to Take Deposition of Andrea Brown on December 8, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 48 | NOTICE to Take Deposition of K.K.C. Dasarathi on November 17, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 49 | NOTICE to Take Deposition of Mohammad Abdul Shafee on November 29, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 50 | NOTICE to Take Deposition of Santosh Guntamukkala on November 15, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 51 | NOTICE to Take Deposition of Sudhakar Koudinya Tippabhotla on November 18, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 52 | NOTICE to Take Deposition of V. Naga Prasad on November 21, 2022 filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Severance, Dana) (Entered: 09/26/2022) (2) |
| Sep 21, 2022 | 44 | NOTICE OF SERVICE of Defendants Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-14) filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 09/21/2022) (2) |
| Sep 13, 2022 | 43 | NOTICE OF SERVICE of Defendants Initial Invalidity Contentions and production of known invalidating references filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 09/13/2022) (2) |
| Aug 23, 2022 | 42 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (Nos. 1-14) filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) (Entered: 08/23/2022) (2) |
| Aug 15, 2022 | 41 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) (Entered: 08/15/2022) (2) |
| Aug 11, 2022 | 40 | NOTICE OF SERVICE of Defendants' Supplemental Initial Disclosures filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) (Entered: 08/11/2022) (2) |
| Aug 9, 2022 | 39 | STIPULATION TO EXTEND TIME to serve initial infringement contentions and initial invalidity contentions to August 15, 2022 and September 13, 2022 - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) (Entered: 08/09/2022) (2) |
| Jul 29, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [38] STIPULATION TO EXTEND TIME for Plaintiffs to produce expert materials from the Fresenius litigation to August 5, 2022. ORDERED by Judge Maryellen Noreika on 7/29/2022. (dlw) |
| Jul 29, 2022 | 38 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to produce expert materials from the Fresenius litigation to August 5, 2022 - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Severance, Dana) |
| Jul 27, 2022 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Production of Documents (Nos. 1-45) filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) |
| Jul 22, 2022 | 36 | Reply Brief (3) Docket Text: REPLY BRIEF re [28] MOTION to Dismiss Based upon Voluntary Dismissal of Claims Related to U.S. Patent Nos. 8,841,081 and 9,877,999 Without Prejudice Under Fed. R. Civ. P. 41(a)(1)(A) filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) |
| Jul 15, 2022 | 35 | Main Document (4) Docket Text: RESPONSE to Motion re [28] MOTION to Dismiss Based upon Voluntary Dismissal of Claims Related to U.S. Patent Nos. 8,841,081 and 9,877,999 Without Prejudice Under Fed. R. Civ. P. 41(a)(1)(A) filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Attachments: # (1) Text of Proposed Order)(Neff, Carl) |
| Jul 15, 2022 | 35 | Text of Proposed Order (1) |
| Jul 7, 2022 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) |
| Jul 5, 2022 | 31 | Protective Order (25) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 7/5/2022. (dlw) |
| Jul 5, 2022 | 32 | Order (12) Docket Text: STIPULATION AND ORDER ON DISCOVERY. Signed by Judge Maryellen Noreika on 7/5/2022. (dlw) |
| Jul 1, 2022 | 28 | Main Document (7) Docket Text: MOTION to Dismiss Based upon Voluntary Dismissal of Claims Related to U.S. Patent Nos. 8,841,081 and 9,877,999 Without Prejudice Under Fed. R. Civ. P. 41(a)(1)(A) - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Attachments: # (1) Text of Proposed Order granting Motion to Dismiss)(Severance, Dana) |
| Jul 1, 2022 | 28 | Text of Proposed Order granting Motion to Dismiss (1) |
| Jul 1, 2022 | 29 | Proposed Order (25) Docket Text: PROPOSED ORDER // Protective Order by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) Modified on 7/5/2022 (dlw). |
| Jul 1, 2022 | 30 | Proposed Order (12) Docket Text: PROPOSED ORDER // Stipulation and Order on Discovery by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) Modified on 7/5/2022 (dlw). |
| Jun 30, 2022 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Initial Disclosures Pursuant to Paragraph 3 of the Courts ESI Default Standard for Discovery filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) |
| Jun 30, 2022 | 27 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Carl Douglas Neff (Neff, Carl) |
| Jun 27, 2022 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) |
| Jun 27, 2022 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1)(A) Disclosures filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) |
| Jun 27, 2022 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-45) filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) |
| Jun 21, 2022 | 22 | Scheduling Order (15) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 10/7/2022. Amended Pleadings due by 10/7/2022. Fact Discovery completed by 12/16/2022. Opening Expert Reports due by 5/19/2023. Rebuttal Expert Reports due by 6/23/2023. Reply Expert Reports due by 7/21/2023. Expert Discovery due by 8/18/2023. Claim Construction Opening Brief served by 2/8/2023. Claim Construction Answering Brief served by 3/1/2023. Claim Construction Reply Brief served by 3/15/2023. Claim Construction Surreply Brief served by 3/22/2023. Joint Claim Construction Brief filed by 3/28/2023. A Markman Hearing is set for 4/28/2023 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 10/10/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 10/23/2023 at 08:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 6/21/2022. (dlw) |
| Jun 7, 2022 | 21 | Proposed Order (15) Docket Text: PROPOSED ORDER // Scheduling Order by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) Modified on 6/8/2022 (dlw). |
| Jun 6, 2022 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-60) filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S.(Bourke, Mary) |
| Jun 2, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [19] MOTION for Pro Hac Vice Appearance of Attorney Joshua P. Davis filed by Polypeptide Laboratories A/S, Ferring B.V., Ferring Pharmaceuticals Inc., Ferring International Center S.A. ORDERED by Judge Maryellen Noreika on 6/2/2022. (dlw) |
| Jun 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joshua P. Davis for Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., and Polypeptide Laboratories A/S added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 2, 2022 | 19 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joshua P. Davis - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) |
| May 31, 2022 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Maryellen Noreika - Telephonic Scheduling Conference held on 5/31/2022. The agreed-upon dates are accepted by the Court. Substantial completion of document production is due by 9/30/2022; the parties shall confer on the remaining dispute(s) and submit an amended proposed scheduling order within one week from today. (Court Reporter Dale Hawkins.) (mdb) |
| May 24, 2022 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER Setting TELEPHONIC Scheduling Conference: IT IS HEREBY ORDERED that a telephonic Scheduling Conference is set for 5/31/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator (diana_welham@ded.uscourts.gov). ORDERED by Judge Maryellen Noreika on 5/24/2022. (dlw) |
| May 23, 2022 | 17 | Main Document (1) Docket Text: Letter to The Honorable Maryellen Noreika from Mary W. Bourke regarding Proposed Scheduling Order. (Attachments: # (1) Text of Proposed Order Proposed Scheduling Order)(Bourke, Mary) |
| May 23, 2022 | 17 | Text of Proposed Order Proposed Scheduling Order (15) |
| May 20, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [16] STIPULATION TO EXTEND TIME to file a proposed scheduling order to May 23, 2022. ORDERED by Judge Maryellen Noreika on 5/20/2022. (dlw) |
| May 19, 2022 | 16 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file a proposed scheduling order to May 23, 2022 - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) |
| May 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] STIPULATION TO EXTEND TIME to file a proposed scheduling order to May 19, 2022. ORDERED by Judge Maryellen Noreika on 5/17/2022. (dlw) |
| May 16, 2022 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file a proposed scheduling order to May 19, 2022 - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) |
| Apr 14, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The bench trial will be set for 10/23/2023. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serve their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 4/14/2022. (dlw) |
| Apr 13, 2022 | 12 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd..(Neff, Carl) |
| Apr 13, 2022 | 13 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Curepro Parenterals Limited, Other Affiliate Celon Laboratories Private Limited for Eugia Pharma Specialties Ltd. filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) |
| Mar 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gongjun Ji and Gurpreet S. Walia for AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Eugia Pharma Specialties Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 21, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [11] MOTION for Pro Hac Vice Appearance of Attorney Gongjun ("Gary") Ji filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd., [10] MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D. filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd. ORDERED by Judge Maryellen Noreika on 3/21/2022. (dlw) |
| Mar 17, 2022 | 10 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D. - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) |
| Mar 17, 2022 | 11 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gongjun ("Gary") Ji - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) |
| Mar 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [9] STIPULATION TO EXTEND TIME for Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and Auromedics Pharma LLC to file its Answer to Plaintiffs' Complaint to April 13, 2022 (Set/Reset Answer Deadlines: AuroMedics Pharma LLC answer due 4/13/2022; Aurobindo Pharma Ltd. answer due 4/13/2022; Eugia Pharma Specialties Ltd. answer due 4/13/2022). ORDERED by Judge Maryellen Noreika on 3/14/2022. (dlw) |
| Mar 11, 2022 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and Auromedics Pharma LLC to file its Answer to Plaintiffs Complaint to April 13, 2022 - filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd.. (Neff, Carl) |
| Jan 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [8] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to March 14, 2022 (Set/Reset Answer Deadlines: AuroMedics Pharma LLC answer due 3/14/2022; Aurobindo Pharma Ltd. answer due 3/14/2022; Eugia Pharma Specialties Ltd. answer due 3/14/2022). ORDERED by Judge Maryellen Noreika on 1/13/2022. (dlw) |
| Jan 13, 2022 | 8 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to March 14, 2022 - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) |
| Jan 12, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) |
| Jan 6, 2022 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S, Ferring B.V., Ferring International Center S.A.. AuroMedics Pharma LLC served on 1/5/2022, answer due 1/26/2022. (Bourke, Mary) |
| Jan 5, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Polypeptide Laboratories Holding AB, Corporate Parent Polypeptide Group AG for Polypeptide Laboratories A/S; Corporate Parent Ferring Holding S.A. for Ferring B.V., Ferring International Center S.A.; Corporate Parent Ferring Holding Inc., Corporate Parent Ferring B.V. for Ferring Pharmaceuticals Inc. filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) |
| Jan 4, 2022 | 1 | Main Document (39) Docket Text: COMPLAINT filed against AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3774264.) - filed by Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S, Ferring B.V., Ferring International Center S.A.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Civil Cover Sheet)(apk) |
| Jan 4, 2022 | 1 | Exhibit A (34) |
| Jan 4, 2022 | 1 | Exhibit B (37) |
| Jan 4, 2022 | 1 | Exhibit C (37) |
| Jan 4, 2022 | 1 | Exhibit D (44) |
| Jan 4, 2022 | 1 | Exhibit E (43) |
| Jan 4, 2022 | 1 | Exhibit F (30) |
| Jan 4, 2022 | 1 | Exhibit G (31) |
| Jan 4, 2022 | 1 | Exhibit H (7) |
| Jan 4, 2022 | 1 | Exhibit I (21) |
| Jan 4, 2022 | 1 | Civil Cover Sheet (2) |
| Jan 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Jan 4, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/25/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 5/25/2024. (apk) |
| Jan 4, 2022 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s)(SEE ATTACHED) (apk) |
| Jan 4, 2022 | 5 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to AuroMedics Pharma LLC on 1/4/2022. (apk) |
| Jan 4, 2022 | 1 | Complaint* (1) |
